Evinature was honored to participate in the GHAPP Eighth Annual National Conference, held September 4–6, 2025, at the Red Rock Resort & Spa. The meeting brought together advanced practice providers at the forefront of GI and liver care—nurse practitioners and physician assistants—for live, APP-designed education and hands-on updates.
At GHAPP, our team introduced the CurQD® Protocol to front-line clinicians managing Crohn’s disease and ulcerative colitis, focusing on how CurQD® can be used alongside standard medical care to support patient outcomes in everyday practice. The APP-focused format—built specifically “by APPs, for APPs”—made it an ideal venue to share evidence, real-world experience, and protocol fit for busy GI clinics.
Beyond the scientific sessions, Evinature engaged providers in the Exhibit Hall (Summerlin Ballroom) for practical discussions about protocol selection and patient support resources. GHAPP’s live, CME/CE-accredited setting (AAPA and ANCC credit available) further underscored the conference’s commitment to advancing APP-led IBD care.
Why GHAPP Matters
GHAPP is recognized as a national forum that concentrates on current concepts and multidisciplinary care in gastroenterology and hepatology—precisely where IBD management is evolving fastest. Bringing CurQD directly to APPs—who often drive day-to-day IBD management protocols—helps accelerate informed adoption and patient-centered implementation.
CurQD® in Clinical Practice
Across the U.S., CurQD® is now being integrated into 40+ medical centers, supporting thousands of IBD patients under clinician guidance. By working alongside standard therapies and informed by real-world use, CurQD® helps providers offer a personalized, evidence-based approach to gut health for the people they care for every day.
Evinature
